Understanding the Potential of CBD for Health Benefits: An Overview
- PMID: 38847170
- DOI: 10.2174/0115701638305553240529103622
Understanding the Potential of CBD for Health Benefits: An Overview
Abstract
Cannabinoids are compounds with increasing scientific interest, particularly due to their interaction with the endocannabinoid system via CBR1 and CBR2 receptors. They can interfere with appetite, pain, and sleep or develop mood changes in the individual. Cannabidiol (CBD) is a well-known cannabinoid with potential benefits, including reducing epilepsy seizures, alleviating anxiety and obsessive-compulsive disorder (OCD) symptoms, aiding in Tourette Syndrome (a neurodevelopmental disorder), depression, sleep disorders, and promising in the treatment of cancer, pain relief, and heart health. Although generally safe, CBD can have side effects, including drug metabolism interference, fertility, and liver function. In addition, it can be administered by oral, sublingual, transdermal, or inhalation via each one with different bioavailability. The application of nanotechnology, specifically through colloidal carrier systems, holds promising potential for maximizing CBD's efficacy and pharmacological profile. There are reported CBD extraction methods using ethanol, carbon dioxide, deionised water, and non-polar oils like olive or coconut oil. Green extraction methods have gained popularity due to their higher yields, shorter extraction time, and reduced costs. A specific dose with the desired effects is challenging due to individual factors, with most studies suggesting a range between less than 1 and 50 mg/kg/d. This review aims to explore the principles of CBD-based products development, focusing on extraction methods and purification processes of this cannabinoid for tinctures, topicals, and other pharmaceutical forms, as well as further research to attain the objectives.
Keywords: CBR1 and CBR2 receptor; Cannabidiol; bioavailability; cannabinoids; nanotechnology; obsessive-compulsive disorder..
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
Similar articles
-
Cannabidiol: Pharmacodynamics and pharmacokinetic in the context of neuropsychiatric disorders.Int Rev Neurobiol. 2024;177:11-27. doi: 10.1016/bs.irn.2024.05.001. Epub 2024 Jul 3. Int Rev Neurobiol. 2024. PMID: 39029981 Review.
-
Cannabidiol Adverse Effects and Toxicity.Curr Neuropharmacol. 2019;17(10):974-989. doi: 10.2174/1570159X17666190603171901. Curr Neuropharmacol. 2019. PMID: 31161980 Free PMC article. Review.
-
Cannabis for the Treatment of Epilepsy: an Update.Curr Neurol Neurosci Rep. 2018 Sep 8;18(11):73. doi: 10.1007/s11910-018-0882-y. Curr Neurol Neurosci Rep. 2018. PMID: 30194563 Review.
-
Cannabinoids as Immune System Modulators: Cannabidiol Potential Therapeutic Approaches and Limitations.Cannabis Cannabinoid Res. 2023 Apr;8(2):254-269. doi: 10.1089/can.2022.0133. Epub 2022 Nov 22. Cannabis Cannabinoid Res. 2023. PMID: 36413346 Review.
-
Cannabidiol Exerts Anticonvulsant Effects Alone and in Combination with Δ9-THC through the 5-HT1A Receptor in the Neocortex of Mice.Cells. 2024 Mar 7;13(6):466. doi: 10.3390/cells13060466. Cells. 2024. PMID: 38534310 Free PMC article.
References
-
- Narouze S.N.; Cannabinoids and pain: Mechanisms of action. Cannabinoids and Pain 2021,191-204 - DOI
-
- DiLonardo M.J.; CBD vs. THC: What’s the Difference? Available from: https://www.webmd.com/pain-management/cbd-thc-difference2019
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous